Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
16 hedge funds and large institutions have $4.3M invested in Alimera Sciences in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less funds holding
Funds holding: 20 → 16 (-4)
30% less capital invested
Capital invested by funds: $6.13M → $4.3M (-$1.83M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$39K |
| 2 |
JP Morgan Chase
New York
|
+$22.9K |
| 3 |
BlackRock
New York
|
+$1.02K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$544K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$91.5K |
| 3 |
Renaissance Technologies
New York
|
-$2.56K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$888 |
| 5 |
MCC
Money Concepts Capital
Palm Beach Gardens,
Florida
|
-$163 |
ALIM Hedge Fund Activity: Q1 2023 in Review
16 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q1 2023, worth a combined $4.3M — down 30% from $6.13M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ALIM and 0 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Millennium Management, adding an estimated $39K. The largest seller was Palo Alto Investors, exiting entirely with an estimated $544K sold.
- 16 institutional investors held Alimera Sciences (ALIM) as of Q1 2023, down from 20 in Q4 2022.
- Funds reported $4.3M of Alimera Sciences stock for Q1 2023, down 30% quarter-over-quarter.
- 0 funds opened new Alimera Sciences positions in Q1 2023 and 4 closed out, a net change of -4 holders.
- The largest Alimera Sciences buyer in Q1 2023 was Millennium Management, an estimated $39K added.
- The largest Alimera Sciences seller in Q1 2023 was Palo Alto Investors, an estimated $544K sold.
Based on aggregated 13F filings for Q1 2023.